Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hillary Haws
Observed names:
Hillary J. Haws,
Hillary Jean Haws
Institution:
Tolero Pharmaceuticals (United States)
Observed institutions:
Brigham Young University,
Tolero Pharmaceuticals (United States)
OpenAlex ID:
A5032408645
Combined venetoclax and alvocidib in acute myeloid leukemia
2017
·
James Bogenberger
, Clifford Whatcott
, et al.
·
Oncotarget
·
95
PDF
Control of cell mechanics by RhoA and calcium fluxes during epithelial scattering
2016
·
Hillary J. Haws
, Melissa A. McNeil
, et al.
·
Tissue Barriers
·
28
PDF
Abstract 5133: TP-1287, an oral prodrug of the cyclin-dependent kinase-9 inhibitor alvocidib
2017
·
Wontak Kim
, Hillary Haws
, et al.
·
Cancer Research
·
18
The ALK-2 Inhibitor, TP-0184, Demonstrates High Distribution to the Liver Contributing to Significant Preclinical Efficacy in Mouse Models of Anemia of Chronic Disease
2016
·
Peter Peterson
, Wontak Kim
, et al.
·
Blood
·
5
Abstract 1106: Alvocidib potentiates the activity of venetoclax in preclinical models of multiple myeloma
2017
·
Mark Livingston
, Wontak Kim
, et al.
·
Cancer Research
·
1
Abstract 883: Alvocidib-mediated inhibition of CDK9 upregulates BIM via suppression of miR17-92
2018
·
Hillary Haws
, Hubert F. Arokium
, et al.
·
Cancer Research
Abstract B178: Targeting Myc in triple-negative breast cancer models through the dual inhibition of PIM kinases and CDK9
2018
·
Hillary Haws
, Wontak Kim
, et al.
·
Molecular Cancer Therapeutics
Alvocidib Potentiates the Activity of Venetoclax in Preclinical Models of Acute Myeloid Leukemia
2016
·
Clifford J. Whatcott
, James M Bogenberger
, et al.
·
Blood
Rab8 Mediates TRPV4 Vesicle Trafficking to the Plasma Membrane in HGF-Stimulated MDCK Cells
2016
·
Hillary Jean Haws
·
ScholarsArchive (Brigham Young University)
PDF
Show more works
View as search
Works count:
9
Citation count:
147
H-index:
4
I10-index:
3
Year
Topic
Type
